213 results on '"van Triest, Baukelien"'
Search Results
2. MRI anatomy of the rectum: key concepts important for rectal cancer staging and treatment planning
3. A Phase 1 Study of the DNA-PK Inhibitor Peposertib in Combination With Radiation Therapy With or Without Cisplatin in Patients With Advanced Head and Neck Tumors
4. Phase I feasibility study of Olaparib in combination with loco-regional radiotherapy in head and neck squamous cell carcinoma
5. Development and validation of prognostic models for anal cancer outcomes using distributed learning: protocol for the international multi-centre atomCAT2 study
6. Patterns of Care, Tolerability, and Safety of the First Cohort of Patients Treated on a Novel High-Field MR-Linac Within the MOMENTUM Study: Initial Results From a Prospective Multi-Institutional Registry
7. Development and results of a patient-reported treatment experience questionnaire on a 1.5 T MR-Linac
8. Pharmacokinetics of docetaxel and ritonavir after oral administration of ModraDoc006/r in patients with prostate cancer versus patients with other advanced solid tumours
9. Trends in epidemiology and primary treatment of anal squamous cell carcinoma in the Netherlands (1990–2021).
10. Sense and non-sense of imaging in the era of organ preservation for rectal cancer
11. A Phase 1 Study of the DNA-PK Inhibitor Peposertib in Combination With Radiation Therapy With or Without Cisplatin in Patients With Advanced Head and Neck Tumors
12. Feasibility of Gold Fiducial Markers as a Surrogate for Gross Tumor Volume Position in Image-Guided Radiation Therapy of Rectal Cancer
13. Prediction of optimal needle configuration in the first fraction of cervix brachytherapy
14. Evaluation of plan quality in radiotherapy planning with an MR-linac
15. Predictive factors for response and toxicity after brachytherapy for rectal cancer; results from the HERBERT study
16. MRI visibility of gold fiducial markers for image-guided radiotherapy of rectal cancer
17. Imaging predictors of treatment outcomes in rectal cancer: An overview
18. Outcomes and potential impact of a virtual hands-on training program on MRI staging confidence and performance in rectal cancer
19. Corrigendum to “Master protocol trial design for technical feasibility of MR-guided radiotherapy” [Radiother. Oncol. 166 (2022) 33–36]
20. Pre-clinical experience of an adaptive plan library strategy in radiotherapy of rectal cancer: An inter-observer study
21. Monitoring early changes in rectal tumor morphology and volume during 5 weeks of preoperative chemoradiotherapy – An evaluation with sequential MRIs
22. Needle use and dosimetric evaluation in cervical cancer brachytherapy using the Utrecht applicator
23. Improved pharmacodynamic (PD) assessment of low dose PARP inhibitor PD activity for radiotherapy and chemotherapy combination trials
24. Supplementary File 6: Pulmonary Function Tests and Pulmonary Adverse Events by Treatment Arm. from Phase I and Pharmacologic Study of Olaparib in Combination with High-dose Radiotherapy with and without Concurrent Cisplatin for Non–Small Cell Lung Cancer
25. Supplementary File 2: Treatment details. from Phase I and Pharmacologic Study of Olaparib in Combination with High-dose Radiotherapy with and without Concurrent Cisplatin for Non–Small Cell Lung Cancer
26. Supplementary File 5: Esophageal Adverse Events. from Phase I and Pharmacologic Study of Olaparib in Combination with High-dose Radiotherapy with and without Concurrent Cisplatin for Non–Small Cell Lung Cancer
27. Supplementary File 3: Dose Limiting Toxicity. from Phase I and Pharmacologic Study of Olaparib in Combination with High-dose Radiotherapy with and without Concurrent Cisplatin for Non–Small Cell Lung Cancer
28. Supplementary File 1: Supplementary Methods. from Phase I and Pharmacologic Study of Olaparib in Combination with High-dose Radiotherapy with and without Concurrent Cisplatin for Non–Small Cell Lung Cancer
29. Supplementary File 4: Adverse Events. from Phase I and Pharmacologic Study of Olaparib in Combination with High-dose Radiotherapy with and without Concurrent Cisplatin for Non–Small Cell Lung Cancer
30. Supplementary File 8: Olaparib Pharmacokinetics. from Phase I and Pharmacologic Study of Olaparib in Combination with High-dose Radiotherapy with and without Concurrent Cisplatin for Non–Small Cell Lung Cancer
31. Supplementary File 7: Loco-regional control and survival. from Phase I and Pharmacologic Study of Olaparib in Combination with High-dose Radiotherapy with and without Concurrent Cisplatin for Non–Small Cell Lung Cancer
32. Endorectal Brachytherapy Boost After External Beam Radiation Therapy in Elderly or Medically Inoperable Patients With Rectal Cancer: Primary Outcomes of the Phase 1 HERBERT Study
33. Radiotherapy quality assurance for mesorectum treatment planning within the multi-center phase II STAR-TReC trial: Dutch results
34. Locally advanced rectal cancer: 3D diffusion-prepared stimulated-echo turbo spin-echo versus 2D diffusion-weighted echo-planar imaging
35. Radiotherapy, atezolizumab, and bevacizumab in rectal cancers with the aim of organ preservation: The TARZAN study.
36. Histopathology-derived modeling of prostate cancer tumor control probability: Implications for the dose to the tumor and the gland
37. Features on Endoscopy and MRI after Treatment with Contact X-ray Brachytherapy for Rectal Cancer: Explorative Results
38. Defining near-complete response following (chemo)radiotherapy for rectal cancer: systematic review
39. NAD+ depletion by APO866 in combination with radiation in a prostate cancer model, results from an in vitro and in vivo study
40. A Multi-institutional Clinical Trial of Rectal Dose Reduction via Injected Polyethylene-Glycol Hydrogel During Intensity Modulated Radiation Therapy for Prostate Cancer: Analysis of Dosimetric Outcomes
41. Low rectal toxicity after dose escalated IMRT treatment of prostate cancer using an absorbable hydrogel for increasing and maintaining space between the rectum and prostate: Results of a multi-institutional phase II trial
42. Thymidine Phosphorylase in Angiogenesis and Drug Resistance : Homology with platelet-derived endothelial cell growth factor
43. Additional file 1 of Development and validation of prognostic models for anal cancer outcomes using distributed learning: protocol for the international multi-centre atomCAT2 study
44. Additional file 2 of Development and validation of prognostic models for anal cancer outcomes using distributed learning: protocol for the international multi-centre atomCAT2 study
45. Defining near-complete response following (chemo) radiotherapy for rectal cancer: systematic review.
46. Contact x-ray brachytherapy for older or inoperable rectal cancer patients: short-term oncological and functional follow-up.
47. Master protocol trial design for technical feasibility of MR-guided radiotherapy
48. Contact X-ray Brachytherapy for Older or Inoperable Rectal Cancer Patients: Short-Term Oncological and Functional Follow-Up
49. MR-Linac Radiotherapy – The Beam Angle Selection Problem
50. Phase II study of definitive chemoradiation for locally advanced squamous cell cancer of the vulva: An efficacy study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.